APRI (Aprinoia Therapeutics) Cash Flow for Dividends: $0.00 Mil (TTM As of Dec. 2023)


What is Aprinoia Therapeutics Cash Flow for Dividends?

Aprinoia Therapeutics APRI Cash Flow for Dividends is $0.00 Mil as of Dec. 2023.

Aprinoia Therapeutics's cash flow for dividends for the six months ended in Dec. 2023 was $0.00 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Aprinoia Therapeutics Cash Flow for Dividends Related Terms

Aprinoia Therapeutics Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Aprinoia Therapeutics's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aprinoia Therapeutics Cash Flow for Dividends Chart

Aprinoia Therapeutics Annual Data
Trend Dec21 Dec22 Dec23
Cash Flow for Dividends
0.00 0.00 0.00

Aprinoia Therapeutics Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Cash Flow for Dividends 0.00 0.00 0.00 0.00 0.00

Aprinoia Therapeutics Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of $0.00 Mil mean?
Aprinoia Therapeutics (APRI) has a Cash Flow for Dividends of $0.00 Mil as of Dec. 2023. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Aprinoia Therapeutics and its competitors.
Is Aprinoia Therapeutics' Cash Flow for Dividends too high?
Aprinoia Therapeutics' current Cash Flow for Dividends is $0.00 Mil.
How does Aprinoia Therapeutics' Cash Flow for Dividends compare to ?
Aprinoia Therapeutics' Cash Flow for Dividends of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Biotechnology company?
A good Cash Flow for Dividends depends on the Biotechnology industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Aprinoia Therapeutics and its competitors. Aprinoia Therapeutics's current Cash Flow for Dividends is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aprinoia Therapeutics stock overvalued right now?
Aprinoia Therapeutics (APRI) has a current Cash Flow for Dividends of $0.00 Mil. The current Cash Flow for Dividends is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Aprinoia Therapeutics (APRI), the current Cash Flow for Dividends is $0.00 Mil as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aprinoia Therapeutics Business Description

Comparable Companies
Address 245 Main Street, 2nd Floor, Cambridge, MA, USA, 02142
Aprinoia Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in protecting patients' brain health and changing clinical outcomes for a broad range of neurodegenerative diseases by developing novel, highly sensitive and selective diagnostic tools and novel therapeutics. Neurodegenerative diseases are relentless and largely fatal, resulting from progressive loss of nerve cells in the brain and, depending on the specific disorders, can affect a broad range of cognitive, behavioral, and motor functions, such as memory, thinking, speaking, walking, and breathing. It is developing several different diagnostic and therapeutic platforms such as abnormal protein aggregates of tau and alpha synuclein ("?-Syn") that are toxic to brain cells.